Medical Cannabis for Endometriosis in the UK

Endometriosis is a chronic condition causing persistent pelvic pain that affects a significant number of people in the UK. Diagnosis is notoriously delayed — the average time from first symptoms to confirmed diagnosis is approximately 7.5 years in the UK according to data from Endometriosis UK — and many patients live with poorly managed pain for years. For those who have not found adequate relief through established treatments, cannabis-based medicines represent an option that can be explored with a specialist clinician.

What is Endometriosis?

Endometriosis is a condition in which tissue similar to the lining of the uterus (the endometrium) grows outside the uterus — most commonly on the ovaries, fallopian tubes, the lining of the pelvic cavity, and the surface of the bowel and bladder. Like the uterine lining, this endometrial-like tissue responds to the hormonal cycle: it thickens, breaks down, and bleeds. However, as this process occurs outside the uterus, the blood and tissue have no route of exit, causing inflammation, adhesions, and scar tissue that can distort pelvic anatomy and cause severe pain.

The principal symptoms of endometriosis include chronic pelvic pain, dysmenorrhoea (severe period pain), dyspareunia (pain during or after sex), dysuria and rectal pain in deep infiltrating disease, significant fatigue, and in some cases reduced fertility. Pain in endometriosis can be cyclical, but in many patients — particularly those with deep infiltrating endometriosis — it becomes persistent throughout the cycle and substantially impairs daily functioning, work capacity, and quality of life.

The diagnostic delay of 7.5 years in the UK reflects the complexity of the condition, its variable presentation, and historic dismissal of women's pain in clinical settings. Definitive diagnosis requires laparoscopy with histological confirmation, though clinical diagnosis is increasingly made to guide earlier treatment. Standard management includes hormonal therapies (combined oral contraceptives, progestins, GnRH analogues) to suppress the hormonal cycle and reduce endometrial growth, and laparoscopic surgical excision of endometriotic lesions for patients with significant disease burden.

A proportion of patients find that hormonal therapies do not adequately control pain, are poorly tolerated, or are unsuitable (for example in those trying to conceive). Following laparoscopy, pain may recur. For this population, the pain management aspects of endometriosis — separate from the hormonal disease management — require dedicated attention, and this is the clinical context in which cannabis-based medicines are most relevant.

Medical Cannabis and Endometriosis — What Does the Evidence Say?

The scientific basis for exploring cannabis-based medicines in endometriosis is strengthening. Cannabinoid receptors — CB1 and CB2 — have been identified in endometriotic lesions themselves, in the uterus, and in nerve fibres supplying pelvic structures. Preclinical studies suggest that cannabinoids may reduce the proliferation and invasiveness of endometrial tissue in laboratory models, and may have anti-inflammatory effects within the peritoneal environment. These findings are preliminary but provide a plausible biological rationale beyond simple pain relief.

Clinical research in humans is at an earlier stage. A landmark Australian study published in 2020 found that self-reported cannabis use in endometriosis patients was associated with significant reductions in pain intensity across multiple pain types, including dysmenorrhoea, pelvic pain, and pain during sex, alongside reductions in nausea and sleep difficulties. This observational data, while not from a randomised controlled trial, reflects meaningful real-world patient experience. A growing number of gynaecologists and pain specialists are acknowledging endometriosis as a condition for which cannabis-based medicines warrant clinical consideration where conventional management has been inadequate.

Who Qualifies for a Medical Cannabis Prescription for Endometriosis?

• Confirmed or clinically diagnosed endometriosis: A gynaecologist-confirmed or clinically diagnosed case of endometriosis, ideally with documentation of lesions or strong clinical evidence of the condition.
• Chronic pelvic pain persisting despite treatment: Persistent pelvic pain, dysmenorrhoea, or other endometriosis-related pain that significantly impairs daily functioning and quality of life despite current management.
• Prior conventional treatment: At least two appropriate treatments tried — typically including hormonal management and/or laparoscopic treatment — without achieving adequate and sustained pain relief.
• Ongoing gynaecological care: Patients should remain under gynaecological care for their endometriosis. Cannabis-based medicines address the pain burden and do not treat the underlying pathological lesions.
• UK residency and adult age.

Endometriosis Cannabis Treatment UK — The Private Prescription Pathway

There is no NHS pathway for cannabis prescribing for endometriosis pain. All prescribing occurs through licensed private specialist clinics under the UK unlicensed specialist prescribing framework, where a GMC-registered specialist can prescribe cannabis-based medicines when clinically appropriate and when conventional treatments have been inadequately effective.

The private prescription pathway for endometriosis:

1. Eligibility check: Confirm you have a diagnosis, a documented treatment history, and ongoing pain despite management.
2. Choose a clinic: Select a UK cannabis clinic that accepts endometriosis as a prescribing indication.
3. Initial consultation: Video consultation with a specialist (typically 30-60 minutes). Fee: £79 to £200.
4. Prescription issue: If appropriate, a prescription is issued for a cannabis-based oil or capsule product.
5. Dispensing: Medication dispensed from a licensed UK pharmacy and delivered to your address.
6. Follow-up: Regular monitoring appointments every 1-3 months.

Which UK Clinics Treat Endometriosis?

Endometriosis is accepted as a prescribing indication by most major UK cannabis clinics. The clinics with the most documented experience in women's health and pelvic pain conditions include:

• Mamedica — endometriosis and chronic pelvic pain are established treatment areas. Initial consultation from £95.
• Releaf — women's health including endometriosis covered. Lowest initial consultation fee from £79.
• Lyphe Clinic — broad pain coverage including pelvic pain conditions. From £99.
• Zerenia — accepts endometriosis referrals as a chronic pain and quality-of-life indication. From £99.
• Sapphire Medical — comprehensive assessment for complex pain presentations. From £150.

See the full UK cannabis clinic comparison for fee and appointment details.

What to Expect from a Medical Cannabis Consultation for Endometriosis

A consultation will explore your pain history comprehensively: when your symptoms began, the nature and severity of pain at different points in your cycle, the impact on your work and relationships, the full history of hormonal and surgical treatments, and any co-occurring conditions such as anxiety or sleep disruption. The prescribing specialist will review your current medications and assess any contraindications. Products most commonly considered for endometriosis-related pain management include CBD-dominant or balanced CBD:THC oral oils, with THC-containing formulations used where pain severity warrants it. Cyclical dosing strategies — adjusting the dose around the menstrual cycle — may be discussed where pain is primarily dysmenorrhoeic. Ongoing monitoring through regular follow-up appointments is an important part of safe prescribing.

How Much Does Medical Cannabis Cost for Endometriosis in the UK?

• Initial consultation: £79 to £200 at a private cannabis clinic.
• Monthly medication: £100 to £350 per month depending on product type and dose.
• Follow-up appointments: £50 to £100 per session, typically monthly for the first few months.

For a full guide to the prescription process, see how to get a medical cannabis prescription in the UK. To compare private prescribers, see UK medical cannabis clinics.

Endometriosis Medical Cannabis Treatment UK — What Patients Report in 2026

Endometriosis medical cannabis treatment in the UK has grown significantly since 2022. Patient-reported outcomes from UK cannabis clinic databases and the broader Project Twenty21 data indicate the following patterns for endometriosis and chronic pelvic pain patients:

• Pain intensity reduction: A substantial proportion of patients report meaningful reductions in dysmenorrhoea and pelvic pain severity after 4–8 weeks of consistent dosing.
• Sleep improvement: Endometriosis-related sleep disruption — a common secondary burden — improves in many patients, particularly with evening or nocturnal CBD-dominant dosing.
• Analgesic reduction: Some patients report reduced reliance on NSAIDs (ibuprofen, mefenamic acid) and opioid-based pain relief, though this should always be managed with clinical oversight.
• Menstrual cycle response: Patients with predominantly cyclical pain often benefit from dose adjustment around the menstrual cycle, with higher doses in the perimenstrual window and maintenance dosing throughout the rest of the cycle.
• Quality of life: Work capacity, relationship quality, and daily functioning are the most commonly reported improvements alongside direct pain measures.

These are self-reported and observational findings, not results from randomised controlled trials. Individual responses vary significantly based on disease severity, product choice, dosing, and co-occurring conditions. Your prescribing specialist will discuss realistic expectations at your consultation.

Endometriosis Cannabis Treatment UK — Frequently Asked Questions

Can you get prescribed medical cannabis for endometriosis in the UK?

Yes. Endometriosis is accepted as a prescribing indication by most major UK licensed cannabis clinics, provided you meet the standard criteria: a confirmed or clinically supported diagnosis, a history of at least two conventional treatments tried without adequate benefit, and current UK residency. A GP referral is not required.

What is the endometriosis cannabis treatment pathway in the UK?

Patients self-refer to a licensed private cannabis clinic, complete an online eligibility check, and book a video consultation with a GMC-registered specialist. If clinically appropriate, a Schedule 2 prescription is issued. Medication is dispensed by a licensed UK pharmacy and delivered by post. The full process typically takes two to four weeks from first enquiry to first delivery.

Frequently Asked Questions — Medical Cannabis for Endometriosis UK

Can medical cannabis treat endometriosis itself?

Cannabis-based medicines are prescribed to manage pain and associated symptoms, not to treat the underlying endometriotic lesions. Preclinical research suggests cannabinoids may have anti-proliferative effects on endometrial tissue, but this has not been established in human clinical trials. Cannabis prescribing for endometriosis is a pain management intervention, not a disease-modifying treatment.

I have not been officially diagnosed — can I still get a prescription?

A confirmed or clinically supported diagnosis is required before a cannabis specialist will prescribe. If you have suspected endometriosis but no formal diagnosis, pursuing gynaecological assessment should be the first step. Endometriosis UK can provide guidance on accessing diagnosis pathways in the UK.

Can I use cannabis-based medicines alongside hormonal treatment?

Your prescribing specialist will review potential interactions between cannabis-based medicines and your hormonal therapy. Significant pharmacokinetic interactions with most hormonal contraceptives and GnRH analogues are not well established, but full disclosure of current medications is essential before any cannabis medicine is started.

Will cannabis-based medicines affect my fertility?

Some preclinical research raises questions about the effects of cannabinoids — particularly THC — on reproductive hormones and implantation. If you are actively trying to conceive, this must be discussed openly with both your gynaecologist and your cannabis prescribing specialist before any treatment is commenced.

How long before I know if medical cannabis is helping my endometriosis pain?

A meaningful clinical assessment typically requires four to eight weeks of consistently titrated dosing. For cyclical pain, at least two to three menstrual cycles of treatment are usually needed before the pattern of response can be properly evaluated. Your specialist will schedule follow-up within this timeframe.